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Abstract. 
 
Most normal cells require adhesion to extra-
cellular matrix for survival, but the molecular mecha-
nisms that link cell surface adhesion events to the intra-
cellular apoptotic machinery are not understood. Bcl-2 
family proteins regulate apoptosis induced by a variety 
of cellular insults through acting on internal mem-
branes. A pro-apoptotic Bcl-2 family protein, Bax, is 
largely present in the cytosol of many cells, but redis-
tributes to mitochondria after treatment with apopto-
sis-inducing drugs. Using mammary epithelial cells as a 
model for adhesion-regulated survival, we show that 
detachment from extracellular matrix induced a rapid 
translocation of Bax to mitochondria concurrent with a 
conformational change resulting in the exposure of its 
BH3 domain. Bax translocation and BH3 epitope expo-
sure were reversible and occurred before caspase acti-
vation and apoptosis. Pp125FAK regulated the confor-
mation of the Bax BH3 epitope, and PI 3-kinase and 
pp60src prevented apoptosis induced by defective 
pp125FAK signaling. Our results provide a mechanistic 
connection between integrin-mediated adhesion and 
apoptosis, through the kinase-regulated subcellular dis-
tribution of Bax.
Key words: apoptosis • Bax • mammary • adhesion • 
pp125FAK
 
Introduction
 
Most normal cells require adhesion to extracellular matrix
(ECM)
 
1
 
 for cell growth, differentiation and survival. Ad-
hesion dependence permits cell differentiation and growth
only when the cell is in its correct environment within the
organism. Cells that become displaced from their appropri-
ate locations are deleted by apoptosis, a highly regulated
process by which unwanted or damaged cells are destroyed
without inducing an inflammatory response (Meredith et
al., 1993; Frisch and Francis, 1994). Apoptosis is tightly
controlled and its deregulation leads to degenerative con-
ditions or to the survival of abnormal cells, contributing to
the development of tumors. In the mammary gland, lumi-
nal epithelial cells are dependent upon adhesion to ECM
for survival (Boudreau et al., 1995; Pullan et al., 1996; Far-
relly et al., 1999; Streuli and Gilmore, 1999). Primary mam-
mary epithelial cells show a specific requirement for a
laminin-rich basement membrane for survival, and un-
dergo apoptosis over several days if they are cultured on
collagen I (Pullan et al., 1996). Laminin acts as a survival
 
ligand through 
 
b
 
1
 
 integrins and cooperates with signals
from insulin to suppress mammary epithelial apoptosis
(Farrelly et al., 1999). However, the molecular mechanisms
that link adhesion events at the cell surface to the intracel-
lular apoptotic machinery are not understood.
Apoptosis induced by a wide variety of factors, from
growth factor starvation to cytotoxic drugs, occurs as a de-
fined sequence of events. The apoptotic stimulus or insult
must initially be sensed and transduced to the apoptotic
machinery, but only after commitment to apoptosis does
the execution phase occur through caspase activation.
Members of the Bcl-2 family appear to function at a piv-
otal point in the decision process where cells become irre-
versibly committed to die. Some members of this family,
including Bcl-x, Bcl-2, Bcl-w, and Mcl-1 promote cell sur-
vival, whereas others, such as Bax, Bak, Bad, Bik, Bid, Bok,
and Bim promote apoptosis (Adams and Cory, 1998).
These molecules form both homo- and heterodimers, and
one possible mechanism for their control on apoptosis is
that the relative proportions of their interactions regulate
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the balance between apoptosis and survival, much like a
rheostat (Yin et al., 1994). However, other data indicates
that their pro- and anti-apoptotic functions are at least
partially independent of their ability to interact with each
other (Cheng et al., 1996; Simonian et al., 1996; Knudson
and Korsmeyer, 1997; Simonian et al., 1997; St. Clair et al.,
1997; Metcalfe et al., 1999). The crystal structure of Bcl-x
suggests a potential to form membrane pores, and indeed
Bcl-x, Bcl-2, and Bax all form pores in artificial bilayers
(Muchmore et al., 1996; Minn et al., 1997). A number of
Bcl-2 family members have a predicted transmembrane
sequence at their carboxyl terminus, which localizes them
to internal cell membranes including mitochondria and the
ER. These proteins may act at the mitochondrial mem-
brane by directly or indirectly inducing the release of
proapoptotic molecules such as caspase 9 and cytochrome
c (Kluck et al., 1997; Zou et al., 1997; Narita et al., 1998;
Krajewski et al., 1999; Shimizu et al., 1999). Thus, although
the mechanism of commitment to apoptosis is not yet fully
understood, it may involve changes in mitochondrial per-
meability that are regulated by Bcl-2 family proteins.
Bax has been reported to be predominantly cytosolic in
healthy cells, despite having a membrane-targeting carboxyl
terminus. Bax translocates to mitochondria in a number of
cell types after receipt of a death signal, such as cytotoxic
insult (Hsu et al., 1997; Wolter et al., 1997; Goping et al.,
1998; Gross et al., 1998; McGinnis et al., 1999). Deletion of
the carboxy-terminal tail prevents Bax translocation and
apoptosis after a death stimulus, suggesting that the regu-
lation of its association with mitochondrial membranes
may be a key stage in transduction of an apoptotic signal
(Wolter et al., 1997). Indeed, enforced dimerization of Bax
results in its constitutive targeting to mitochondria, result-
ing in apoptosis in FL5.15 cells (Gross et al., 1998). Bcl-2
family proteins have a number of conserved sequences
termed BH domains (for Bcl-2 homology domains). The
BH1, BH2, BH3, and BH4 domains have critical functions
in determining the pro- and anti-apoptotic properties of
the various family members, and are involved in mediating
interactions between them. The BH3 domain of Bax is a
region of the molecule that is critically important for the
apoptosis-inducing ability of the protein (Zha et al., 1996a;
Cosulich et al., 1997; Wang et al., 1998). Mitochondria-tar-
geted Bax requires a functional BH3 domain in order to
induce apoptosis. At least two domains of Bax are there-
fore required for its pro-apoptotic activity, a region that
specifies its translocation to organelle membranes includ-
ing mitochondria, and its BH3 domain.
Cells adhere to the ECM through a family of hetero-
dimeric transmembrane receptors, the integrins. Signaling
pathways regulated by adhesion include tyrosine and serine/
threonine kinase activation, as well as changes in cellular
pH, intracellular calcium and phospholipids (Schwartz et
al., 1995). The tyrosine kinase pp125FAK (focal adhesion
kinase) has been implicated as a central molecule for inte-
grin-mediated signaling. Upon integrin ligation and clus-
tering, pp125FAK becomes phosphorylated and activated,
leading to its association with other kinases and adapter
molecules, including PI 3-kinase, pp60src, p130CAS, paxil-
lin and Grb2, which in turn leads to activation of down-
stream pathways (Aplin et al., 1998; Schwartz and Baron,
1999). Pp125FAK is therefore poised to regulate adhesion-
 
dependent cell phenotypes including survival (Gilmore and
Romer, 1996; Zhao et al., 1998). Indeed, inhibition of
pp125FAK by injection of anti-FAK antibodies or by ex-
pression of a dominant negative FAK results in apoptosis
in serum-deprived fibroblasts and cancer cell lines (Hunger-
ford et al., 1996; Ilic et al., 1998), whereas expression of con-
stitutively activated pp125FAK leads to the anchorage-
independent survival of MDCK cells (Frisch et al., 1996).
However, although pp125FAK is a candidate for regulat-
ing adhesion-mediated survival, a link between pp125FAK
and apoptosis regulatory proteins has not been identified.
In this paper, we sought to define the mechanism by
which adhesion to ECM regulates the apoptotic machin-
ery. Since Bcl-2 family proteins have a central role in apop-
tosis induced by a wide variety of different cellular insults,
we investigated the possibility that their function is con-
trolled by adhesion-mediated signaling. We found that the
apoptotic protein Bax was largely present in the cytosol of
adherent mammary epithelial cells. Detachment from
ECM induced a rapid, but reversible, translocation of Bax
to mitochondria concurrent with a conformational change
resulting in the exposure of its BH3 domain. Bax translo-
cation and BH3 epitope exposure occurred before com-
mitment to apoptosis. We identified a critical role for ki-
nase cascades in adhesion-regulated survival signaling and
suggest that conformation of the Bax BH3 epitope is de-
pendent on both pp125FAK and PI 3-kinase.
 
Materials and Methods
 
Cell Culture and Apoptosis Assays
 
Primary mouse mammary cells, isolated from pregnant ICR mice (Pullan
and Streuli, 1996), and FSK-7 cells (Kittrell et al., 1992), were grown in
DMEM/F12 supplemented with 2% fetal calf serum, 5 ng/ml epidermal
growth factor and 880 nM insulin. To assay detachment-induced apopto-
sis, confluent cells were trypsinized and replated in whole medium onto
dishes coated with polyhydroxyethylmethacrylate (poly-HEMA). In the
case of inhibitor experiments, cells were preincubated with inhibitors 1 h
before trypsinization and throughout incubation on poly-HEMA. Inhibitors
were obtained from Calbiochem and used at the following concentrations:
cycloheximide was used at 25 
 
m
 
g/ml, zVAD-fmk, and Ac-DEVD-cmk at
100 
 
m
 
M, herbimycin A at 1 
 
m
 
M, and wortmannin at 1 
 
m
 
M; pervanadate
was used at 1 mM from sodium orthovanadate and hydrogen peroxide
(Sigma), and treated with catalase (Sigma) to quench unreacted hydrogen
peroxide. After incubation for various times, cells were cytospun onto poly-
sine slides (Merck), and fixed in 2% paraformaldehyde. To quantify apop-
tosis, nuclear morphology was examined after staining cells with 4 
 
m
 
g/ml
Hoescht 33258 (Molecular Probes). To analyze DNA integrity after incuba-
tion on poly-HEMA, cells were washed in PBS and lysed in 100 mM NaCl,
10 mM EDTA, 25 mM Tris-Cl, pH 8.0, 0.65% SDS, and 500 
 
m
 
g/ml protein-
ase K. Lysates were extracted with phenol/chloroform (1:1). DNA was
ethanol precipitated, treated with RNase and separated on a 1.5% agarose
gel containing ethidium bromide.
 
Protein Extraction and Immunoblotting
 
For fractionation studies, cells were washed once in PBS before resus-
pending in hypotonic buffer (10 mM NaCl, 1.5 mM MgCl
 
2
 
, 10 mM Tris-Cl,
pH 7.6, 1 mM NaFl, and 100 
 
m
 
M sodium orthovanadate, containing pro-
tease inhibitors) and lysed in a Dounce homogenizer before addition of
5
 
3
 
 isotonic buffer (525 mM mannitol, 172 nM sucrose, 12.5 mM Tris-Cl,
pH 7.6, and 2 mM EDTA). Cytosolic and membrane fractions were then
centrifuged at 100,000 
 
g
 
. Equivalent amounts of protein were separated by
SDS-PAGE and immunoblotted (Metcalfe et al., 1999). For cross-linking
experiments, after incubations, cells were washed in PBS twice before in-
cubating with 2.5 mM disuccinimidyl suberate (Pierce) in 200 mM manni-
tol, 70 mM sucrose, 1 mM EDTA, and 10 mM Hepes, pH 7.5, for 30 min.
The reaction was stopped by adding Tris-Cl, pH 7.6, to 20 mM. The total 
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lysates were boiled in SDS-PAGE sample buffer and immunoblotted with
polyclonal anti-Bax 62M (Metcalfe et al., 1999), anti-calnexin (Stress
Gen), and anti-active caspase 3 (a kind gift from Anu Srinvasan, Idun
Pharmaceuticals, Inc., La Jolla, CA), and monoclonal rat anti-Bax (Phar-
Mingen), mouse anti–Bcl-x (Transduction laboratories), and mouse anti-
COX I (Molecular Probes).
 
Microinjection
 
GST fusion proteins were expressed in 
 
E
 
.
 
 coli
 
 and purified on glutathione-
agarose (Sigma) as previously described (Gilmore and Romer, 1996). FSK-7
cells were grown to confluence on coverslips before microinjecting with ei-
ther GST alone or with the GST-tagged dominant negative pp125FAK
 
(DN-FAK) fusion protein at 3 mg/ml in 75 mM KCl, and 10 mM potas-
sium phosphate, pH 7.5. Cells were fixed in 2% paraformaldehyde either
1 or 5 h postinjection before immunostaining.
 
Transient Transfections
 
The plasmid pSG5.p110CAAX was a generous gift of Dr. Julian Down-
ward (ICRF, London, UK). TS-pp60src was kindly given by Dr. Ged
Brady (University of Manchester, Manchester, UK). Both were subcloned
into the expression vector pCDNA.3 to produce pCDNA.3/p110CAAX
and pCDNA.3/src. pCMV3R
 
D
 
p85 (referred to in text as p85
 
D
 
SH2) was
kindly provided by Dr. Phill Hawkins (Babraham Institute, Cambridge,
UK). Full-length murine Bax was cloned by PCR using 
 
pfu
 
 DNA poly-
merase (Stratagene) from RNA isolated from adult mouse mammary
gland using PCR primers directed against the 5
 
9
 
 and 3
 
9
 
 ends of the coding
sequence. HA-tagged Bax and Bax truncated at its carboxyl terminus at
residue 172 (Bax
 
D
 
CT) were generated by PCR using the 5
 
9
 
 primer ATG-
TACCCATACGACGTCCCAGACTACGCCATGGACGGGTCC, in-
corporating the HA epitope tag. TCAGCCCATCTTCTTCCAGAT was
used as the 3
 
9
 
 primer for Bax, and TCACTGCCATGTGGGGGTCCC
for Bax
 
D
 
CT. Both were cloned into pCR-script SK
 
1
 
 (Stratagene) and con-
firmed by double stranded sequencing, before subcloning into pCDNA.3 to
produce pCDNA.3/HA-Bax and pCDNA.3/HA-Bax
 
D
 
CT. GST-tagged
DN-FAK (amino acids 839-1052) was amplified by PCR using the 5
 
9
 
 primer
GCCGCCATGTCCCCTATACTA, and the 3
 
9
 
 primer TCAGTGTGGC-
CGTGTCTG, and cloned into pCDNA.3.
FSK-7 cells plated onto coverslips at 1 
 
3
 
 10
 
5
 
 cells/cm
 
2
 
 were grown to
80–90% confluence before transfecting using lipofectamine plus (GIBCO
BRL). Cells were transfected with a total of 3 
 
m
 
g DNA. For cotransfec-
tions, 2 
 
m
 
g of pCDNA.3/DN-FAK was used with 1 
 
m
 
g of pCDNA.3,
pCDNA.3/p110CAAX or pCDNA.3/src. Cells were transfected for 3 h
followed by 18 h incubation in growth medium. Detached cells were col-
lected and cytospun onto polysine-coated slides. Both the adherent and
the detached cells were immunostained. DN-FAK– or p85
 
D
 
SH2-express-
ing cells with apoptotic morphology were counted.
 
Immunofluoresence
 
Cells were fixed in 2% paraformaldehyde in PBS and permeabilized in
0.5% Triton X-100. Cells were stained with anti-Bax 62M, anti-GST (Phar-
macia) or the p85 subunit of PI 3-kinase (Upstate Biotechnology Inc.) in
PBS with 0.1% horse serum, followed by either Cy2- or Cy3-conjugated
secondary antibodies (Jackson Laboratories). Cells were counterstained
with 4 
 
m
 
g/ml Hoescht 33258. Cells were viewed on a Zeiss Axiophot photo-
microscope equipped with epifluorescence and images were taken on
T-MAX 400 film. For comparison of Bax staining, all exposures and sub-
sequent image manipulations were identical. For visualization of mito-
chondria, cells were incubated for 15 min before fixation with 500 nM Mi-
totracker green-fm (Molecular Probes).
 
Results
 
Detachment-induced Apoptosis in Mammary Epithelial 
Cells Is Preceded by Redistribution of Bax from a 
Cytosolic to an Insoluble Fraction
 
Mammary epithelial cells require integrin-mediated adhe-
sion to ECM for survival (Streuli and Gilmore, 1999). Pri-
mary mammary epithelial cells have been shown to un-
dergo apoptosis when plated onto an inappropriate ECM
(Pullan et al., 1996; Farrelly et al., 1999). This dependence
on ECM was confirmed by the rapid onset of apoptosis
when mammary cells were detached from their substrata
and maintained in suspension by plating onto nonadhesive
poly-HEMA. After detachment, nucleosomal DNA ladders
were detectable after 3–5 h, along with a loss of cell num-
ber and increase in the proportion of cells showing mor-
phological changes associated with apoptosis (Fig. 1). De-
tachment therefore served to synchronize apoptosis in
ECM-dependent mammary epithelial cells. We examined
a number of mammary cell lines and found that these also
Figure 1. Cultured primary mammary epithelial cells and mam-
mary cell lines undergo apoptosis after detachment from ECM.
(a) Confluent primary mouse mammary epithelial cells and FSK-7
cells were detached by trypsinization and maintained on poly-
HEMA coated dishes for the indicated times before low molecu-
lar mass DNA was extracted and analyzed on 1.2% agarose gels
stained with ethidium bromide. (b and c) Cells were incubated in
the absence of adhesion on poly-HEMA coated dishes for the in-
dicated times before being cytospun onto glass slides. The num-
ber of apoptotic cells was determined by Hoechst 33258 staining
and counting of cells with typically apoptotic nuclear morphol-
ogy, indicated by the arrows in c. Error bars represent SEM. 
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showed a strong dependence upon ECM for survival. The
mouse mammary cell line, FSK-7, showed rapid apoptotic
laddering when maintained on poly-HEMA (Fig. 1 a), with
a time course similar to that observed for primary cells.
This occurred with a loss of 60% in cell number by 24 h,
and an increase in the number of cells showing the con-
densed and fragmented nuclei indicative of apoptosis (Fig.
1, b and c).
We wished to investigate the possible role of members
of the Bcl-2 family in the ECM regulation of mammary
cell survival. FSK-7 cells express a number of the known
Bcl-2 family proteins, including Bax and Bcl-x. The major
pro-apoptotic member of this family in FSK-7 cells, Bax,
has previously been shown to display a cytosolic distribu-
tion in a number of cell types, but redistributes to mito-
chondria when cells are treated with apoptosis-inducing
drugs (Hsu et al., 1997).
To determine if redistribution of endogenous Bax was
involved in apoptosis of mammary cells detached from
ECM, we compared Bax localization in FSK-7 cells in
monolayer culture and after culture on poly-HEMA. Cells
were lysed by swelling in a hypotonic buffer, followed by
Dounce homogenization. The efficacy of homogenization
was checked by trypan blue staining, and found to be
 
.
 
95%. The soluble and insoluble fractions were separated
by centrifugation and the relative distribution of Bax was
analyzed by immunoblotting (Fig. 2 a). In healthy mono-
layer culture, where apoptotic cells represented 
 
,
 
4% of
the population, Bax was predominantly found in the cyto-
sol. However, in cells maintained on poly-HEMA for 1 h,
Bax showed a marked redistribution to the insoluble frac-
tion. The mitochondrial marker cytochrome oxidase I in-
dicated that equivalent amounts of the insoluble fractions
were loaded, also confirmed using the ER marker protein
calnexin. The lack of these proteins in the cytosol indicated
that the presence of Bax in the cytosolic compartment was
not due to organelle disruption. We also examined the ma-
jor pro-survival member of the Bcl-2 family expressed in
FSK-7 cells, Bcl-x. This was primarily associated with the in-
soluble fraction, both in adherent cells and those in suspen-
sion. Thus, loss of adhesion to ECM results in a rapid relo-
calization in the subcellular distribution of Bax.
Translocation of Bax to internal cell membranes, medi-
ated by its carboxy-terminal domain, has previously been
shown to be required for Bax apoptotic function in COS-7
cells (Wolter et al., 1997). We confirmed that this was also
the case in mammary epithelia by transfecting FSK-7 cells
with HA-tagged Bax with or without the hydrophobic car-
boxyl terminus (HA-Bax and HA-Bax
 
D
 
CT). Transfected
cells were examined for apoptotic morphology (Fig. 2 b).
We found that overexpression of HA-Bax induced three
times more apoptosis than HA-Bax
 
D
 
CT. These results in-
dicate that in FSK-7 cells, membrane targeting of Bax is
required for it to induce apoptosis.
The redistribution of Bax occurred within 1 h after detach-
ment from ECM, well before the appearance of apoptotic
markers such as nuclear condensation. Bax remained associ-
ated with the insoluble fraction of cells throughout pro-
longed culture in suspension, while cells were undergoing
apoptosis (Fig. 2 c). Redistribution of Bax was not associated
with any change in the total amount of the protein detected,
and was, therefore, unlikely to require the de novo synthesis
of Bax. This was confirmed by treating cells for 1 h before
detachment from ECM with cycloheximide, which had no
effect on its redistribution to the insoluble fraction (Fig. 2 d).
 
Bax Redistribution Occurs to Mitochondria
 
To determine whether Bax translocated to an identifiable
subcellular compartment, cells were stained with a poly-
clonal antibody raised against a peptide corresponding to
amino acids 44–59 of Bax (62M) (Metcalfe et al., 1999).
Figure 2. Subcellular distribution of Bax in
mammary epithelial cells is altered after de-
tachment from ECM. (a) Adherent FSK-7
cells were either maintained on tissue culture
dishes or were detached from ECM and incu-
bated on poly-HEMA for 1 h. Cells were frac-
tionated into insoluble (Insol) and cytosolic
(Cyt) fractions as described in Materials and
Methods. Fractions were analyzed by immu-
noblotting for Bax, Bcl-x, calnexin, and cyto-
chrome oxidase subunit I (COX I). Similar re-
sults were obtained for primary mammary
epithelial cells. Data are representative of mul-
tiple experiments. (b) FSK-7 cells were trans-
fected with 2 mg of pCDNA.3, pCDNA.3/
HA-Bax, or pCDNA.3/HA-BaxDCT. 18 h af-
ter transfection cells were stained with Hoechst
33258, anti-HA mAb and 62M anti-Bax.
Transfected cells were scored for percent
apoptotic cells based on nuclear morphol-
ogy. (c) FSK-7 cells were detached from ECM
and maintained on poly-HEMA for 5 and 12 h
before homogenization and separation into
insoluble and cytosolic fractions. Fractions
were analyzed by immunoblotting with 62M anti-Bax and monoclonal anti–Bcl-x. (d) FSK-7 cells were treated with 25 mg/ml cyclohex-
imide for 1 h before detachment from ECM for 3 h. Cells were fractionated and Bax localization analyzed by immunoblotting with 62M. 
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Figure 3. Detachment-
induced Bax relocalization
occurs to mitochondria and
coincides with a conforma-
tional change that exposes its
BH3 domain. (a) Adherent
FSK-7 cells and detached
cells maintained on poly-
HEMA for the indicated
times before cytospinning
onto polysine slides, were
immunostained with anti-
Bax 62M and Hoechst 33258.
(b) FSK-7 cells on poly-
HEMA for 1 h were in-
cubated with Mitotracker
before cytospinning and
immunostaining for Bax.
(c)  Adherent cells or cells on
poly-HEMA for the indi-
cated times were treated for
30 min with either the cell
permeable cross-linker DSS
or carrier alone. Total cell ly-
sates were then analyzed by
immunoblotting for Bax or
Bcl-x. No change in Bcl-x
immunoreactivity was ob-
served after DSS treatment.
Results are representative of
three experiments.
 
This region of Bax is at its amino terminus and close to the
BH3 domain critical for its pro-apoptotic function (Hunter
and Parslow, 1996). FSK-7 cells maintained in suspension
for 1, 6, and 24 h were cytospun onto polysine-coated
slides and Bax staining was compared with that in an ad-
herent monolayer of cells (Fig. 3 a). Detachment from
ECM resulted in a marked increase in Bax staining, which
showed a punctate distribution within the cytoplasm. This
occurred within 1 h of detachment, on a time course iden-
tical with the observed translocation of Bax to the insolu-
ble fraction of the cells, and preceding the onset of apopto-
sis, seen through the condensation and fragmentation of
nuclei at 6 and 24 h (compare Fig. 3 a with 1 b). To deter-
mine if Bax localized to mitochondria, detached cells were 
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incubated with the mitochondrial stain Mitotracker green-
fm before fixation and immunostaining with the 62M anti-
body. This is incorporated into the mitochondria of live
cells, but is retained after aldehyde fixation. Bax immuno-
fluorescence in detached cells was found to coincide with
Mitotracker staining (Fig. 3 b). The relocation of Bax to an
insoluble fraction after detachment from ECM therefore
coincided with the exposure of its BH3 domain and its ap-
pearance within mitochondria.
To verify that the conformation of the Bax BH3 epitope
altered during detachment-induced apoptosis, living FSK-7
cells were treated with the membrane permeable cross-
linker DSS. Cells were treated with DSS before lysis, and
compared with untreated cells. In the absence of cross-
linking, there was no change in the total amount of Bax
present over the time course of the experiment. However,
we observed very little Bax immunoreactivity with the
62M antibody in whole cell lysates after cross-linking of
proteins within monolayers of cells adherent to ECM (Fig.
3 c). After detachment, however, Bax immunoreactivity in-
creased with a time course similar to that observed both for
redistribution of Bax to the insoluble fraction and for the in-
crease in Bax immunofluorescence. A similar result was
seen with a second anti-Bax antibody (data not shown).
As with Bax translocation, the increase in Bax immunoreac-
tivity after cross-linking was not blocked by treating cells on
Figure 4. Detachment-
induced Bax redistribution
precedes activation of caspases
and cytochrome c release.
(a) 100 mM of the caspase in-
hibitors, DEVD or zVAD-fmk,
were added 1 h before de-
tachment of FSK-7 cells from
ECM, and throughout the in-
cubation on poly-HEMA for
3 h. Cells were homogenized
in hypotonic buffer and in-
soluble and cytosolic frac-
tions were analyzed with the
62M anti-Bax antibody.
(b) FSK-7 cells with or with-
out caspase inhibitors were
maintained on poly-HEMA
for 1 h before immunostain-
ing for Bax. (c) FSK-7 cells
were maintained on poly-
HEMA for 24 h in the pres-
ence or absence of either
zVAD or DEVD. Cells were
cytospun onto glass slides be-
fore immunostaining with
anti-activated caspase 3 and
Hoechst 33258. Both the per-
centage of apoptotic cells
and the number of cell re-
maining  were determined.
Caspase inhibitors reduced
both the loss of cell number
and the percentage apoptosis
in the remaining cells.
(d) FSK-7 cells were left at-
tached to ECM or detached
and maintained in the pres-
ence or absence of DEVD.
Whole cell lysates were
analyzed by immunoblot-
ting with the antibody to
activated caspase 3, CM1.
(e) FSK-7 cells, either adher-
ent or detached and main-
tained on poly-HEMA for 3 h,
were fractionated and the dis-
tribution of cytochrome c com-
pared with Bax. 
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poly-HEMA with inhibitors of caspases (data not shown;
see below). Together, the results of our immunostaining
and cross-linking studies indicate that Bax is normally
present in the cytosol but that its BH3 domain is con-
cealed. Loss of mammary epithelial cell interactions with
the ECM result in a rapid translocation of Bax to mito-
chondria, coinciding with a conformational change to ex-
pose its BH3 domain.
 
Bax Redistribution Occurs before Commitment to 
Apoptosis and Is Reversible
 
The rapidity of Bax redistribution after detachment sug-
gested that it was an event upstream of the execution phase
of apoptosis. Treating cells on poly-HEMA with the broad
spectrum caspase inhibitor zVAD-fmk, or the caspase 3–like
inhibitor DEVD, did not prevent the redistribution of Bax
to the insoluble compartment of FSK-7 cells (Fig. 4 a) or the
appearance of the BH3 proximal epitope (Fig. 4 b). Caspase
inhibitors did, however, reduce detachment-induced apop-
tosis and inhibit the activation of caspase 3 (Fig. 4, c and
d). We also examined the distribution of cytochrome c.
Bax can induce cytochrome c release from isolated mito-
chondria (Jurgensmeier et al., 1998; Narita et al., 1998),
and overexpression of Bax can induce cytochrome c release
in fibroblasts and melanoma cells (Rosse et al., 1998). How-
ever, in hematopoietic cells, Bax association with mito-
chondria does not result in cytochrome c release, but does
result in mitochondrial dysfunction and apoptosis (Wolter
et al., 1997; Gross et al., 1998). At 3 h after detachment
from ECM, cytochrome c was still associated with the in-
soluble fraction, even though Bax had redistributed from
the cytosol (Fig. 4 e). This also provided further evidence
that mitochondrial integrity had not been affected during
homogenization. The results indicate that the adhesion-
dependent relocation of Bax occurs before caspase activa-
tion.
Bax translocation occurred upstream of the execution
phase of apoptosis. To determine if it was reversible, FSK-7
cells were detached and maintained on poly-HEMA for 1 h,
after which a portion were then replated onto laminin be-
fore they had committed to apoptosis. After 1 h in suspen-
sion, Bax relocated to the insoluble fraction (Fig. 5 a) and
its BH3 domain became exposed (Fig. 5 b). After replating
for 4 h, 94.3% (
 
6
 
3.9 SEM,
 
 n 
 
5 
 
3) of the cells reattached
and spread, and in those cells Bax redistributed back to
the soluble fraction. The extent of BH3 domain exposure
determined by Bax immunostaining, diminished after re-
plating for 3 h and was absent after 18 h. To confirm that
the reattached cells had not committed to apoptosis, bro-
modeoxyuridine (BrdU) was included in the growth me-
dium for 24 h, and the cells were fixed and stained with a
monoclonal antibody to BrdU. There was no difference
between the percentage of replated cells that incorporated
BrdU with those constantly maintained on ECM (data not
shown). Together, these results indicate that detachment-
induced translocation of Bax to the insoluble fraction oc-
curs upstream of commitment to apoptosis and is reversible.
Since the adhesion of mammary epithelial cells to laminin is
mediated by 
 
b
 
1
 
 integrins (Klinowska et al., 1999), our re-
sults also demonstrate that Bax translocation and BH3 do-
main epitope exposure are integrin dependent.
 
Signaling Pathways Associated with Cell Adhesion 
Regulate Bax Translocation
 
The tyrosine phosphorylation of a number of integrin-
associated signaling proteins has been shown to be central
to adhesion-mediated signal transduction (Howe et al., 1998).
We therefore determined whether either the subcellular
distribution of Bax or mammary cell apoptosis was regulated
by tyrosine kinases. The protein tyrosine kinase inhibitor,
herbimycin A prevents adhesion-induced tyrosine phosphor-
ylation of focal adhesion proteins, including pp125FAK and
its targets (Burridge et al., 1992). Herbimycin A treatment
Figure 5. Bax relocalization and exposure of its BH3 domain is
reversible. (a) Adherent FSK-7 cells were detached from ECM
and maintained on poly-HEMA for 1 h. Half were then homoge-
nized and fractionated. The other half were replated onto lami-
nin for 4 h before homogenization. Insoluble and cytosol frac-
tions were analyzed by immunoblotting for Bax. (b) FSK-7 cells
were immunostained for Bax. Cells were adherent, detached
from ECM for 1 h, or detached for 1 h and then replated onto
laminin for 3 or 18 h. Note that Bax staining is diminished 3 h af-
ter plating on ECM and is virtually absent after 24 h. 
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of adherent FSK-7 cells induced apoptosis, seen by the ap-
pearance of nucleosomal ladders (Fig. 6 a). It also resulted
in translocation of Bax from the soluble to the insoluble
fraction (Fig. 6 b), but had no effect on the total amount of
expressed Bax or the distribution of Bcl-x. In addition,
treatment with herbimycin A for 5 h resulted in an in-
crease in punctate staining of the Bax BH3 epitope, similar
to that observed in cells maintained on poly-HEMA (Fig.
6 c). All the attached cells showing increased Bax staining
had normal nuclei, whereas all those cells that had de-
tached after 5 h herbimycin A treatment were apoptotic,
with condensed and fragmented nuclei, and all showed in-
tense punctate Bax staining. Thus, inhibition of tyrosine
kinases in adherent cells induced the exposure of the Bax
BH3 domain epitope and its translocation from the cytosol
to the insoluble fraction, and this preceded the onset of
apoptosis.
To confirm that protein tyrosine kinases were involved
with the adhesion-dependent regulation of Bax transloca-
tion and mammary epithelial cell apoptosis, detached cells
maintained on poly-HEMA were treated with the protein
tyrosine phosphatase inhibitor pervanadate. Pervanadate
completely inhibited detachment-induced apoptosis, even
after 24 h in suspension (Fig. 6 d). Treatment with pervan-
adate also prevented Bax translocation to the insoluble
fraction after detachment (Fig. 6 e). Similar results were
also seen with orthovanadate alone, and in control experi-
ments hydrogen peroxide alone did not suppress apoptosis
Figure 6. Adhesion-dependent subcellular local-
ization of Bax and apoptosis are regulated by
protein tyrosine kinases. (a) Adherent FSK-7
cells were treated with 1 mM herbimycin A in
DMSO or with DMSO alone, or were main-
tained on poly-HEMA. Cells were treated for 24 h
before harvesting and extracting low molecular
mass DNA for analysis of nucleosomal ladders.
(b) Adherent FSK-7 cells were treated with 1 mM
herbimycin A or carrier alone, or maintained on
poly-HEMA, for 3 h. Cells were then lysed in hy-
potonic buffer and fractionated by Dounce ho-
mogenization. Bax localization was analyzed by
immunoblotting. Treatment with herbimycin A
resulted in an increase in the amount of Bax as-
sociated with the insoluble fraction. (c) Adher-
ent FSK-7 cells were treated with 1 mM her-
bimycin A for 5 h before fixation in 3.7%
formaldehyde and staining with anti-Bax 62M
and Hoechst 33258 to visualize nuclei. Cells
treated with carrier alone only showed weak
staining with 62M. Herbimycin A–treated cells
showed an increase in the punctate Bax staining
as seen in detached FSK-7 cells (compare with
Figs. 3 and 4). Treatment of cells with herbi-
mycin A resulted in a number of cells detaching
from the monolayer. These cells were cytospun
onto polysine slides and stained for Bax. All dis-
played condensed and fragmented nuclei, typical
of apoptosis, and stained strongly for Bax.
(d) FSK-7 cells were detached and maintained
on poly-HEMA with or without pervanadate.
Cells were harvested at 3, 5, and 24 h. Low mo-
lecular mass DNA was isolated and separated on
1.2% agarose to assay nuclear laddering. Pervan-
adate completely inhibited the appearance of
DNA ladders, even after 24 h culture on poly-
HEMA. (e) Cells cultured either as an adherent
monolayer, or as detached cells on poly-HEMA
with or without pervanadate, were lysed in hypo-
tonic buffer and fractionated into insoluble and
cytosolic fractions. Fractions were separated by
SDS-PAGE and analyzed by immunoblotting
with anti-Bax 62M and anti–Bcl-x antibodies.
Pervanadate-treated cells still show predomi-
nantly soluble Bax. Note the apparent reduction
in mobility of Bax after pervanadate treatment,
which is not seen with Bcl-x. 
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(data not shown). These results suggest that Redox effects
were not responsible for inhibition of apoptosis. Interest-
ingly, Bax from pervanadate-treated cells also demon-
strated a slight but reproducible decrease in mobility as
seen by SDS-PAGE and immunoblotting. This was not
due to direct tyrosine phosphorylation of Bax, as Bax was
not detectable using anti-phosphotyrosine antibodies, nei-
ther was Bax phosphorylation detected in immunoprecipi-
tates from 
 
32
 
P-orthophosphate labeled cells. The cause for
this mobility shift is, therefore, not yet clear. Pervanadate
treatment had no effect on the distribution of Bcl-x or its
mobility on SDS-PAGE. Together, these results indicate
that protein tyrosine kinases are central in mediating ad-
hesion-regulated subcellular localization of Bax and apop-
tosis.
 
Bax Localization and Conformation Is Regulated
by pp125FAK
 
Pp125FAK has previously been reported to regulate adhe-
sion-dependent cell survival in serum starved fibroblasts
(Hungerford et al., 1996; Ilic et al., 1998). To determine if
inhibition of pp125FAK signaling in mammary epithelial
cells resulted in apoptosis and altered exposure of the Bax
BH3 epitope, its activity was inhibited by using dominant
negative FAK constructs. A dominant negative pp125FAK,
consisting of its carboxy-terminal region fused to glu-
tathione-
 
S
 
-transferase (DN-FAK), contains the focal adhe-
sion-targeting sequence of pp125FAK but lacks the kinase
domain and the critical tyrosine phosphorylation site at Tyr-
397 required for interaction with src and PI 3-kinase. This
construct has previously been shown to displace endoge-
nous pp125FAK from the focal adhesions of fibroblasts and
endothelial cells (Gilmore and Romer, 1996).
To ascertain whether or not pp125FAK was required for
survival in mammary epithelia, FSK-7 cells were trans-
fected with either DN-FAK or pCDNA.3 alone, and the
number of apoptotic cells determined 24 h later. DN-FAK
induced almost five times the amount of apoptosis seen
with vector alone, and this was inhibited with zVAD-
fmk (Fig. 7 a). To examine whether DN-FAK regulated
Bax conformation, transfected cells were immunostained
using the BH3 proximal antibody (62M). DN-FAK–
expressing cells that showed apoptotic morphology
stained strongly with 62M, whereas there was little im-
munoreactivity in nonexpressing cells with healthy nuclei
(Fig. 7 b). 24 h after transfection, DN-FAK–expressing
cells that had undergone apoptosis had mostly detached,
and these cells were cytospun before immunostaining.
Virtually all detached apoptotic cells stained positive both
for DN-FAK and the 62M anti-Bax antibody. DN-FAK–
expressing cells also stained strongly with the activated
caspase 3 antibody (data not shown).
Using transfections, we were unable to examine the time
course of Bax epitope exposure after inhibition of
pp125FAK signaling. Therefore, to address early events
after inhibition of pp125FAK signaling, DN-FAK protein
was microinjected into FSK-7 cells. Cells were then as-
sayed at 1 and 5 h postinjection (Fig. 7 c). FSK-7 cells in-
jected with DN-FAK showed a marked inhibition of phos-
photyrosine staining in focal adhesions 1 h after injection
compared with noninjected cells and to cells injected with
 
the GST control (data not shown). At 5 h postinjection,
there was an increase in the proportion of DN-FAK–
injected cells with apoptotic morphology, whereas very few
GST-injected cells showed abnormal morphology (Fig. 7
c). Not all the DN-FAK–injected cells became apoptotic
after 5 h, possibly due to each cell receiving different doses
of the fusion protein, as was found previously in endothe-
lial cells and fibroblasts where the DN-FAK inhibitory ef-
fect was highly dose dependent (Gilmore and Romer,
1996). We also examined exposure of the Bax BH3
epitope after DN-FAK injection. Immunostaining using
the 62M antibody increased in a proportion of DN-FAK–
injected cells within 1 h of injection (Fig. 7 d). This staining
showed a similar pattern of staining to that seen in FSK-7
cells on poly-HEMA, with a punctate distribution. These
results demonstrate that injection of DN-FAK protein in
adherent mammary cells leads to rapid exposure of its
BH3 epitope within 1 h, followed by the induction of apop-
tosis in a high proportion of cells within 5 h. Thus in ad-
herent cells, pp125FAK is required to maintain survival
and inhibiting its function results in rapid Bax BH3 do-
main exposure, followed by apoptosis.
To determine whether Bax was required for DN-FAK–
induced apoptosis, the BH3 proximal antibody 62M was coin-
jected into FSK-7 cells with the fusion proteins. Cells were
then examined 5 h post injection. Whereas DN-FAK–induced
cell death when coinjected with nonspecific rabbit IgG, there
was no loss of cells when injected together with 62M (Fig. 7 e).
Thus, antibody binding near the critical BH3 domain required
for apoptosis prevented Bax apoptotic function. Injection
with either antibody (IgG or 62M) together with GST had no
significant effect on apoptosis. These results provide evidence
that the exposure of the Bax BH3 epitope is required for
apoptosis induced by inhibiting pp125FAK signaling.
 
Pp125FAK Mediates Apoptosis through PI 3-Kinase 
and pp60src
 
Pp125FAK can activate a number of downstream signal-
ing pathways (Hanks and Polte, 1997). PI 3-kinase and
pp60src both bind to pp125FAK (Chen and Guan, 1994;
Cobb et al., 1994) and have been implicated in survival sig-
naling (Khwaja et al., 1997; McGill et al., 1997). To de-
termine if pp125FAK mediated mammary cell survival
through either PI 3-kinase or pp60src, DN-FAK was
cotransfected with either the constitutively active p110
subunit of PI 3-kinase (p110CAAX) or with activated
pp60src. Both active PI 3-kinase and pp60src blocked DN-
FAK–induced apoptosis (Fig. 8 a). Previously, pp125FAK
has been shown to promote survival of primary fibroblasts
through a PKC- and p53-dependent pathway and not
through a PI 3-kinase route (Ilic et al., 1998). To confirm
that PI 3-kinase was required for MEC survival, FSK7
cells were transfected with a dominant negative p85 sub-
unit (p85
 
D
 
SH2). This induced apoptosis as efficiently as
DN-FAK (Fig. 8 a). We examined the exposure of the Bax
BH3 domain in p85
 
D
 
SH2-transfected cells. Cells express-
ing p85
 
D
 
SH2 stained strongly with the 62M antibody and
showed apoptotic nuclei, whereas healthy untransfected
cells were negative for Bax BH3 epitope exposure (Fig. 8
b). The p85
 
D
 
SH2-expressing cells that had detached after
apoptosis were also examined after cytospinning, and 
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Figure 7. Mammary epithelial cell apoptosis and Bax BH3 epitope exposure is regulated by pp125FAK. (a) FSK-7 cells were trans-
fected with either DN-FAK or vector alone, in the presence of either 100 mM zVAD or carrier alone. 24 h post transfection, the number
of apoptotic cells were determined by Hoechst staining. (b) DN-FAK–transfected FSK-7 cells were immunostained 24 h posttransfec-
tion for GST and Bax using anti-Bax 62M. Both adherent cells and cells that had detached after apoptosis were stained. DN-FAK–
expressing cells showing Bax staining were apoptotic, whereas all nonexpressing cells showed healthy nuclei and were negative for Bax
immunoreactivity (examples of healthy nontransfected cells are indicated by arrows). All detached cells were Bax positive and had apop-
totic nuclei. (c) Adherent FSK-7 cells were microinjected with either 3 mg/ml GST or GST-tagged DN-FAK protein. Cells were fixed
1 and 5 h postinjection, followed by immu-
nostaining for GST to identify injected cells.
Cells were stained with Hoechst 33258 and
the percentage of apoptotic cells that were
GST-positive were scored based on nuclear
condensation/fragmentation. (d) Adherent
FSK-7 cells were microinjected with GST or
DN-FAK protein and fixed 1 h postinjection.
Cells were double immunostained for GST
and Bax using the anti-Bax 62M antibody.
Note the appearance of Bax staining in the
cell microinjected with DN-FAK, but absence
of staining in cells injected with GST alone.
(e) Adherent FSK-7 cells were microinjected
with either GST or DN-FAK protein, together
with either anti-Bax 62M or rabbit IgG. In-
jected cells were identified by immunostaining
with anti-GST, and the number of apoptotic
cells determined.
 
these all showed Bax epitope exposure (Fig. 8 b). Simi-
larly, treatment of FSK-7 cells with the PI 3-kinase inhibi-
tor wortmannin resulted in apoptosis and translocation of
Bax to the insoluble fraction (data not shown). Bax
epitope exposure was inhibited in cells that had been
cotransfected with DN-FAK and either p110CAAX or src,
consistent with the hypothesis that signaling through PI
3-kinase and src linked pp125FAK with suppression of Bax
activation (Fig. 8 c). Together with the fibroblast study (Ilic
et al., 1998), these results indicate that pp125FAK might
suppress apoptosis using cell type–specific signaling path-
ways. We suggest that in mammary epithelial cells, the acti-
vation of pp125FAK by integrin-mediated adhesion to ECM
may act through downstream kinases such as PI 3-kinase to
regulate the conformation and subcellular distribution of
Bax, thereby controlling apoptotic fate.
 
Discussion
 
ECM is an important determinant for epithelial cell sur-
vival (Frisch and Francis, 1994; Boudreau et al., 1995;
Khwaja et al., 1997; Farrelly et al., 1999), but until now the
components that link adhesion to the apoptotic machinery
have not been identified. In this paper, we demonstrate
that detachment of epithelial cells from ECM results in re-
versible changes in the conformation and localization of
Bax before the onset of apoptosis. We have identified
early decision making events in this process, as ECM inter-
actions suppress apoptosis through signaling pathways ac-
tivated by the integrin-associated kinase pp125FAK. Our
results suggest that pp125FAK, through PI 3-kinase and
pp60src, maintains Bax in a conformation that prevents its
relocation to mitochondria. Bax translocation is upstream 
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of caspase activation, indicating that it is an early event af-
ter inhibition of adhesion-dependent survival signals.
 
Survival Signaling in Mammary Epithelial Cells Is 
Mediated through pp125FAK
 
Most cells require adhesion to ECM for survival. This has
now been demonstrated for primary cultures of endothe-
lial, epithelial, fibroblastic, mesangial, muscle, and neu-
ronal cells. Furthermore, survival signaling in these cell
systems is mediated through integrins (Meredith et al.,
1993; Frisch and Francis, 1994; Vachon et al., 1996; Ilic et
al., 1998; Farrelly et al., 1999; Frost et al., 1999; Mooney et
al., 1999). Here we show that mammary cells undergo ex-
tremely rapid apoptosis after complete detachment from
the ECM. Our previous work has shown that long-term
survival of mammary epithelial cells in culture requires in-
tegrin-mediated interactions with a laminin-rich basement
membrane. Monolayers of cells on collagen I or on tissue
culture plastic undergo apoptosis over a period of several
days (Pullan et al., 1996; Farrelly et al., 1999). Thus, even
though collagen I does not provide as efficient survival sig-
nals as laminin, it does afford some protection to apoptosis
compared with complete detachment from ECM. In both
Figure 8. The p110 subunit
of PI 3-kinase and pp60src
act downstream of pp125FAK
in adhesion-mediated apop-
tosis suppression. (a) FSK-7
cells were transfected with
2  mg pCDNA.3 (mock), 2 mg
pCDNA.3/DN-FAK (DN-
FAK), 2 mg pCDNA.3/DN-
FAK  1 1 mg pCDNA.3/
p110CAAX (DN-FAK1
p110CAAX), 2 mg pCDNA.3/
DN-FAK 1 1 mg pCDNA.3/
src (DN-FAK1src), and
2  mg pCDNA.3/p85DSH2
(p85DSH2). 24 h after trans-
fection the adherent cells
were stained with Hoechst
33258 and either anti-GST or
anti-p85 (for the p85DSH2-
transfected cells), and the
percentage of adherent trans-
fected cells were scored for
apoptosis. Detached cells
were cytospun and the num-
ber of cells expressing DN-
FAK or p85DSH2 were
counted. (b) FSK-7 cells
transfected with pCDNA.3/
p85DSH2 were immuno-
stained 24 h posttransfection
with anti-p85 and anti-Bax
62M, as well as Hoechst 33258
to visualize nuclei. P85DSH2-
expressing cells were positive
for Bax immunoreactivity, as
well as showing apoptotic nu-
clei, in contrast to nonex-
pressing cells which were
Bax negative and had
healthy nuclei (examples of
healthy cells are indicated by
arrows). Detached apoptotic
cells were cytospun before
staining, and all showed p85
and Bax BH3 epitope immu-
noreactivity. (c) FSK-7 cells
were cotransfected with DN-
FAK and p110CAAX or src
as in a, 24 h later, cells were
fixed and immunostained for
GST and Bax, as well as
Hoechst 33258. 
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cases, apoptosis occurs even in the presence of serum
growth factors, including insulin and EGF, demonstrating
the primal nature of the ECM-derived survival signal.
Pp125FAK represents an excellent candidate signaling
protein for transducing adhesion-mediated survival sig-
nals. It has been shown to be a key apoptosis regulator in
several cell types including fibroblasts, human cancer cell
lines, and MDCK epithelial cells (Frisch et al., 1996; Hun-
gerford et al., 1996; Ilic et al., 1998; Xu et al., 1998; Sonoda
et al., 1999). Our work now implicates an essential role for
pp125FAK in mammary cell survival since both microin-
jected DN-FAK protein and transfected DN-FAK expres-
sion vectors induce apoptosis rapidly. Although we cannot
totally discount the possibility that DN-FAK disrupts cell
adhesion, and thus induces apoptosis, we think this is un-
likely. First, DN-FAK did not disrupt focal adhesions
when microinjected into fibroblasts and primary endothe-
lial cells, although it did block downstream signaling
(Gilmore and Romer, 1996). Second, the number of de-
tached cells resulting from DN-FAK transfection was re-
duced by treatment with zVAD-fmk, indicating that detach-
ment was due to apoptosis rather than disruption of adhesion
by DN-FAK. Third, activated mutants of PI 3-kinase and src
also reduced the number of cells detaching after DN-FAK
transfection. Together these observations suggest that de-
tachment follows apoptosis in DN-FAK–expressing cells
and not vice versa.
A variety of downstream effectors may propagate sur-
vival signals from pp125FAK, as it lies in a nodal position
for effecting integrin-dependent cellular responses and
can potentially act through PI 3-kinase, pp60src, as well as
adapter molecules such as Grb2, paxillin and p130CAS
(Chen and Guan, 1994; Schlaepfer et al., 1994; Schaller
and Parsons, 1995; Cary et al., 1996; Chen et al., 1996; Cary
et al., 1998; Thomas et al., 1998). One candidate signaling
kinase is PI 3-kinase, which regulates apoptosis in kidney
epithelial cells as well as in neuronal and hematopoietic
cells (Minshall et al., 1996; Dudek et al., 1997; Khwaja et
al., 1997; Philpott et al., 1997; Vaillant et al., 1999). A po-
tential role for PI 3-kinase in adhesion-mediated survival
signaling comes from experiments where the expression of
constitutively activated PI 3-kinase as well as one of its
substrates, protein kinase B, protects MDCK cells from
apoptosis in suspension (Khwaja et al., 1997), and where
adhesion to fibronectin directly results in the accumula-
tion of PI 3-kinase lipid products as well as p85-dependent
protein kinase B activity (King et al., 1997). In the mam-
mary system we have previously demonstrated that
apoptosis is induced by pharmacological inhibitors of PI
3-kinase (Farrelly et al., 1999), and now show that cell death
results from expression of the dominant negative p85 sub-
unit of PI 3-kinase, whereas apoptosis induced by DN-
FAK is suppressed by the constitutively active p110 sub-
unit of PI 3-kinase. Since adhesion to ECM leads to the
association of PI 3-kinase with pp125FAK and its activation
in several cell types (Chen and Guan, 1994; Chen et al.,
1996; King et al., 1997), including mammary epithelial cells
(our unpublished data), it would seem to be a likely down-
stream effector of pp125FAK-mediated survival signaling.
However, the plethora of binding sites for signaling mol-
ecules on FAK suggests that it may regulate survival
through different mechanisms in different cell types. This
is borne out at both the cellular and molecular levels, as
detachment of fibroblasts from ECM, for example, does
not lead to rapid apoptosis induction as is the case for epi-
thelia (Frisch and Francis, 1994). In serum-starved rat syno-
vial fibroblasts, DN-FAK induced apoptosis, but this was
not reversed by activating the PI 3-kinase pathway (Ilic et
al., 1998). In this cell type, pp125FAK acted through a
p53-dependent pathway involving the 
 
l
 
/
 
i
 
 isoform of pro-
tein kinase C and phospholipase A2. Further experiments
showing that PI 3-kinase inhibition did not induce apop-
tosis suggests that fibroblasts may be independent of PI
3-kinase for survival. Thus, whereas PI 3-kinase is important
in epithelia, it may not be a primary determinant of adhe-
sion-mediated survival in other cell types such as synovial
fibroblasts.
Other pp125FAK-mediated pathways than PI 3-kinase
may also be involved with epithelial cell survival. Constitu-
tively active pp125FAK can suppress apoptosis in MDCK
cells detached from ECM, but only if its kinase domain
and its major autophosphorylation site, Y-397, are intact
(Frisch et al., 1996). Y-397 binds src family kinases in addi-
tion to PI 3-kinase. This association has been proposed
to regulate the phosphorylation of cellular substrates
through the recruitment of src to focal adhesions (Schaller
et al., 1999). In mammary cells we found that activated
pp60src also suppressed the apoptotic effects of DN-FAK.
Furthermore, transformation by src has been implicated
in reducing the sensitivity of fibroblasts to detachment-
induced apoptosis (McGill et al., 1997). Whether or not PI
3-kinase and pp60src trigger similar or independent down-
stream pathways leading to apoptosis suppression is not
yet clear. Pp125FAK effects on cell proliferation, through
Erk activation, appear to be regulated by Y-397 binding to
src and fyn kinase, whereas its regulation of migration also
requires an association with p130CAS through one of
two carboxy-terminal proline rich domains (Cary et al.,
1998; Zhao et al., 1998). Recently, it has been suggested
that pp125FAK can activate Jun amino-terminal kinase
through a mechanism not requiring pp125FAK kinase ac-
tivity, but involving an interaction with paxillin through
its extreme carboxy-terminal region (Igishi et al., 1999).
Thus, the many interactions of pp125FAK with down-
stream signaling pathways might permit several mecha-
nisms for regulating apoptosis.
 
Linking Integrin Signals to the Apoptosis Machinery
 
Adhesion provides an essential anti-apoptotic signal for
epithelial cells, yet the mechanism by which it feeds into
the apoptotic machinery has not been elucidated. We
demonstrate in this paper that whatever the proximal sur-
vival pathway regulated by pp125FAK, adhesion regulates
apoptosis through a Bax-dependent mechanism.
Previously, integrin-mediated adhesion has been shown
to upregulate expression of Bcl-2 in CHO cells, which was
proposed to lead to survival according to the rheostat model
(Zhang et al., 1995). However, in mammary epithelia Bcl-2
is absent and we have seen no changes in the levels of ex-
pression of Bax or Bcl-x either after detachment from ma-
trix or during culture on different ECM substrata (Pullan et
al., 1996). Thus, at least in mammary epithelia, altered ra-
tios of these proteins do not seem to regulate apoptosis. 
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Instead, we find that cell-ECM interactions control Bax
translocation between the cytosol and mitochondria. Al-
though Bax is a pro-apoptotic death effector, we argue
that adhesion-dependent signaling maintains Bax in the
cytosol where it is unable to trigger apoptosis. In response
to lack of integrin-mediated survival signals, Bax translo-
cates to a cellular environment where it can initiate apop-
tosis. Although Bax has been found constitutively associ-
ated with internal cell membranes in some cell types
(Desagher et al., 1999), GFP-Bax chimeras had a predomi-
nantly cytosolic distribution in Cos-7 cells and in other cell
types Bax was cytosolic until receipt of a death stimulus,
at which point redistribution to mitochondria occurred
(Wolter et al., 1997; Goping et al., 1998; Gross et al., 1998).
In common with all but the BH3-only proteins in the
Bcl-2 family, Bax has a hydrophobic carboxy-terminal tail
of 
 
z
 
20 amino acids. This tail contains a mitochondrial-tar-
geting domain, and directs unrelated peptides to mito-
chondria (Nguyen et al., 1993; Wolter et al., 1997; Ne-
chushtan et al., 1999). Targeting of Bax to internal
membranes appears to be critical for its ability to induce
apoptosis, as deletion of the hydrophobic tail abrogates
the ability of Bax to induce apoptosis not only in our ex-
periments with mammary epithelia but also in Cos-7 cells
and L929 fibroblasts (Wolter et al., 1997). Thus, regulation
of Bax targeting to internal cell membranes may be a criti-
cal regulatory step in apoptosis.
Concomitant with the translocation of Bax from the cy-
tosol to mitochondria is a conformational change that may
be important for its regulation. In hematopoietic cells the
amino terminus of Bax is inaccessible to a monoclonal an-
tibody when the protein is in a cytosolic form but be-
comes exposed during translocation associated with an
apoptotic stimulus (Hsu et al., 1997). In our studies an an-
tibody recognizing an epitope just amino-terminal to its
BH3 domain becomes exposed after cell detachment from
ECM or upon expression of DN-FAK in adherent cells.
The Bax BH3 domain is necessary for the induction of
apoptosis, as peptides resembling this domain have apop-
tosis-inducing ability, and substitution of the Bcl-2 BH3
region with that of Bax converts Bcl-2 into a pro-apoptotic
protein (Hunter and Parslow, 1996; Cosulich et al., 1997).
This would indicate that masking of the BH3 domain is re-
quired to maintain survival in healthy cells, but its expo-
sure after an apoptotic stimulus may be an essential part of
the commitment process. This suggestion is supported by
our own experiments, where coinjection of DN-FAK with
the Bax BH3 proximal antibody inhibited the apoptotic ef-
fect of the fusion protein. The result directly implicates
control of BH3 domain exposure with adhesion-mediated
survival signals. The related molecule Bak, shows similar
changes in antibody reactivity after treatment of lym-
phoma cells with DNA damaging agents (Griffiths et al.,
1999). However, in this case, although Bak undergoes a
conformational change to expose an amino-terminal do-
main during the early stages of apoptosis commitment, it is
constitutively associated with mitochondria. Conforma-
tional changes associated with the exposure of the death-
inducing BH3 domain may therefore be a common mecha-
nism of activation within the Bcl-2 family in response to a
wide variety of cellular insults.
It not yet resolved how Bax conformation and subcellu-
lar localization are controlled, but both its amino and car-
boxyl termini have been implicated. Deletion of the amino
terminus results in dysregulated translocation of in vitro–
translated Bax to purified mitochondria, whereas replac-
ing the carboxyl terminus of Bax with the corresponding
sequence of Bcl-2, which is constitutively targeted to mem-
branes, also results in constitutive targeting of Bax (Go-
ping et al., 1998). A further point of regulation may be
through phosphorylation, although it is unclear whether
Bax can be directly phosphorylated. We did not detect
phosphorylated Bax in mammary cells radiolabeled with
 
32
 
P-orthophosphate, even though other phosphoproteins
were readily identified. The BH3-only protein Bad, for ex-
ample, appears to be suppressed in its apoptosis-inducing
ability by IL-3–mediated phosphorylation of S-112 and
S-136, which provides binding sites for the chaperone pro-
tein 14-3-3. After IL-3 withdrawal, Bad becomes dephos-
phorylated and translocates to mitochondria (Zha et al.,
1996b; Datta et al., 1997). Bax expressed in 
 
E
 
.
 
 coli
 
 can be
phosphorylated on serine residues by both protein kinase
A and MAP kinase (Lewis et al., 1998), although it is not
yet known whether this has relevance to Bax regulation in
vivo. We found that tyrosine kinase inhibitors induced Bax
translocation to mitochondria and BH3 domain epitope
exposure in mammary epithelia. Likewise, the protein ki-
nase C inhibitor staurosporine, induced relocalization of
Bax in Cos-7 cells (Wolter et al., 1997). It will therefore be
important to determine whether kinase-mediated Bax lo-
calization occurs through direct or indirect means.
It remains possible that Bax function is regulated by a
chaperone. Intriguingly, in vitro–translated Bax was un-
able to associate with mitochondria unless it had been ex-
posed to a cell lysate derived from apoptotic cells (Goping
et al., 1998). Bax does not contain consensus 14-3-3–bind-
ing sites, and in our own experiments Bax did not associate
with 14-3-3 (unpublished data), which would implicate the
involvement of other proteins. One possibility is the BH3-
only protein, Bid, although this is unlikely in mammary epi-
thelia as we have been unable to detect it in FSK-7 cells (un-
published data). Bid resides in the cytoplasm of healthy
cells and does not induce apoptosis, but after cleavage by
caspase 8, which is activated by death receptors such as
TNFR and FAS, Bid was found to bind Bax and induce
exposure of the Bax amino-terminal region (Green, 1998;
Desagher et al., 1999). This suggests that in some cell
types, Bid can regulate Bax activity. Recently, caspase 8
has been shown to be activated after MDCK cell detach-
ment from ECM (Frisch, 1999; Rytomaa et al., 1999).
However, it is not clear whether Bax activation is depen-
dent upon caspase 8 since zVAD, which inhibits caspase 8,
blocked neither Bax translocation to mitochondria in
mammary cells in our studies, nor the appearance of Bax
immunoreactivity in HeLa cells treated with staurosporine
(Desagher et al., 1999). Many questions remain to be an-
swered regarding the precise control of pro-apoptotic Bcl-2
proteins, and it is quite possible that this regulation shows
distinct tissue specific variations.
In summary, we have now identified one potential mech-
anism whereby adhesion can regulate commitment to apop-
tosis in epithelial cells. Integrin-mediated positional control
is required for maintaining homeostasis, and defective inte-
grin signals lead normal cells to commit apoptosis. By alter- 
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ing the level or activity of integrin-regulated enzymes that
control apoptosis, such as pp125FAK, PI 3-kinase and
pp60src, malignant cells may subvert positional information
and survive in inappropriate environments. Thus, therapeu-
tic intervention at specific or multiple points on this path-
way might restore both the Bax dynamics and the mitotic/
apoptotic balance in human cancer.
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